Fig. 3From: Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA levelKaplan–Meier (a) progression-free survival (PFS), (b) overall survival (OS), c locoregional relapse-free survival (LRFS), and d distant metastasis-free survival (DMFS) curves for the 742 stage IVa-b NPC patients receiving induction TPF, PF, or TPBack to article page